Enliven Therapeutics
ELVNInsider trades and stock quote 2024-2026
All insider trades at Enliven Therapeutics
Subscribe RSS| Date | Type | Insider | Position | Ø-Price | Volume |
|---|---|---|---|---|---|
| 6/15/2026 | Sell | Orbimed Advisors LLC | Ten Percent Owner | $45.0 | $12,668,988 |
| 6/5/2026 | Sell | Kunkel, Lori Anne | Director | $35.2 | $345,351 |
| 5/18/2026 | Sell | Collins, Helen Louise | CHIEF MEDICAL OFFICER | $40.3 | $198,972 |
| 4/17/2026 | Sell | Collins, Helen Louise | CHIEF MEDICAL OFFICER | $47.1 | $238,351 |
| 3/25/2026 | Sell | Collins, Helen Louise | CHIEF MEDICAL OFFICER | $35.1 | $1,404,024 |
All information without guarantee! No recommendation/consultation!
© U.S. Securities and Exchange Commission (SEC)